<< Back to companies search


ApconiX provides bespoke nonclinical safety strategies to maximise the value of pharmaceutical assets at all stages of drug discovery and development.  From target review to regulatory approval, ApconiX will help organisations to assess, reduce and manage risk and make a better decision on the drug candidate.  We will design and deliver the optimal non-clinical strategy for the rapid implementation of clinical programmes, through to marketing approval, helping organisations bring safe, effective, profitable drugs to market.




Alderley Park Accelerator


Company Type

Lab and office